Literature DB >> 3421724

The influence of heme-binding proteins in heme-catalyzed oxidations.

S H Vincent1, R W Grady, N Shaklai, J M Snider, U Muller-Eberhard.   

Abstract

We show here that heme-binding proteins may enhance, decrease, or completely inhibit heme-catalyzed oxidations and that in doing so the proteins themselves may be oxidized depending upon their relative affinities for heme and the nature of their interactions with this metalloporphyrin. That release of iron from heme was not responsible for the catalytic effect is indicated by the observation that heme induced more peroxidation of rat liver microsomal lipid in the presence of H2O2 than iron and that iron release is very low under the conditions employed. Hemopexin, which binds heme with high affinity, completely inhibited heme-catalyzed lipid peroxidation at concentrations slightly higher than that of heme, suggesting a unique role for this acute phase protein in antioxidant defense mechanisms. The protein itself was not oxidized, presumably because the putative bis-histidyl heme-hemopexin complex cannot interact with H2O2. Rat and human albumin and rat glutathione S-transferases (GST), proteins with moderate affinities for heme, decreased heme-catalyzed lipid peroxidation in a dose-dependent manner but were subject to oxidation. The GST were crosslinked forming a nondisulfide covalently linked subunit dimer as well as products of higher molecular weight whereas the oxidation products of the albumins had molecular weights only slightly higher than those of the native proteins. The changes in the electrophoretic patterns of GST and albumin were accompanied by a decrease in their tryptophan fluorescence and the formation of bityrosine-like products. Proteins with lower affinities for heme, such as bovine albumin and rat liver fatty acid-binding protein (L-FABP), enhanced lipid peroxidation at all concentrations tested. While bovine albumin was modified, L-FABP was not crosslinked nor were its tyrosine residues oxidized. Thus, the susceptibility of a protein to heme-mediated oxidative damage would appear to be determined by factors such as its affinity for heme, the nature of the amino acids in the vicinity of the bound catalyst and the availability of a free coordination site on the iron.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421724     DOI: 10.1016/0003-9861(88)90159-2

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  40 in total

Review 1.  Clinical use of albumin in hepatology.

Authors:  Matteo Garcovich; Maria Assunta Zocco; Antonio Gasbarrini
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

2.  Hemoglobin, horseradish peroxidase, and heme-bovine serum albumin as biocatalyst for the oxidation of dibenzothiophene.

Authors:  T Stachyra; D Guillochon; S Pulvin; D Thomas
Journal:  Appl Biochem Biotechnol       Date:  1996-06       Impact factor: 2.926

Review 3.  Role of heme in bromine-induced lung injury.

Authors:  Adam Lam; Nilam Vetal; Sadis Matalon; Saurabh Aggarwal
Journal:  Ann N Y Acad Sci       Date:  2016-05-31       Impact factor: 5.691

4.  Haemin-enhanced expression of haem oxygenase-1 stabilizes erythrocyte-induced vulnerable atherosclerotic plaques.

Authors:  Hui Li Lin; Lei Zhang; Chun Xi Liu; Xin Sheng Xu; Meng Xiong Tang; Hui Xia Lv; Chang Jiang Li; Hui Wen Sun; Mei Zhang; Jiang Hong; Yun Zhang
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

5.  Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX.

Authors:  Christine Cruz-Oliveira; Andreza F Almeida; João M Freire; Marjolly B Caruso; Maria A Morando; Vivian N S Ferreira; Iranaia Assunção-Miranda; Andre M O Gomes; Miguel A R B Castanho; Andrea T Da Poian
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

6.  Hemopexin decreases hemin accumulation and catabolism by neural cells.

Authors:  Jing Chen-Roetling; Wenpei Liu; Raymond F Regan
Journal:  Neurochem Int       Date:  2012-02-07       Impact factor: 3.921

7.  Altered activity of plasma hemopexin in patients with minimal change disease in relapse.

Authors:  Winston W Bakker; Catharina M L van Dael; Leonie J W M Pierik; Joanna A E van Wijk; Jeroen Nauta; Theo Borghuis; Jola J Kapojos
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

8.  Heme and blood-feeding parasites: friends or foes?

Authors:  Shu Qin Toh; Amber Glanfield; Geoffrey N Gobert; Malcolm K Jones
Journal:  Parasit Vectors       Date:  2010-11-18       Impact factor: 3.876

9.  Protein aggregation as a cellular response to oxidative stress induced by heme and iron.

Authors:  Luiz R C Vasconcellos; Fabianno F Dutra; Mariana S Siqueira; Heitor A Paula-Neto; Jennifer Dahan; Ellen Kiarely; Leticia A M Carneiro; Marcelo T Bozza; Leonardo H Travassos
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

10.  Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states.

Authors:  Peter Hahl; Taron Davis; Cecilia Washburn; Jack T Rogers; Ann Smith
Journal:  J Neurochem       Date:  2013-02-25       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.